Related Experiment Videos

Postoperative wound infections following myocutaneous flap surgery in spinal injury patients

M Garg1, S Rubayi, J Z Montgomerie

  • 1Department of Medicine, Rancho Los Amigos Medical Center, Downey, California 90242.

Paraplegia
|October 1, 1992
PubMed

Insights

Perioperative antibiotics did not fully prevent infections in musculocutaneous flap surgeries for spinal cord injury patients. Anaerobic bacteria, like Bacteroides, were common in infections, suggesting a need for broader antibiotic coverage.

Area of Science:

  • Surgical Oncology
  • Infectious Diseases
  • Reconstructive Surgery

Background:

  • Musculocutaneous (m-c) flap surgery is common for severe pressure ulcers in spinal cord injury patients.
  • Postoperative infection is a significant complication.
  • Limited research exists on perioperative antibiotic efficacy in this specific surgical context.

Purpose of the Study:

  • To evaluate the effectiveness of perioperative antibiotics in preventing postoperative infections following m-c flap surgery for pressure ulcers.
  • To identify common pathogens in postoperative infections to guide antibiotic strategies.

Main Methods:

  • Retrospective review of 74 m-c flap surgeries in 53 spinal cord injury patients over one year.
  • Analysis of surgical sites, patient demographics, antibiotic administration (typically 5 days perioperatively), and follow-up duration (median 30 weeks).
  • Identification of microorganisms cultured from infected wounds.

Main Results:

  • Postoperative infections occurred in 6 of 74 (8%) surgeries, with a median onset of 12 days.
  • Commonly isolated organisms included Bacteroides sp. (4), Proteus mirabilis (2), E. coli (2), and MRSA (2).
  • Perioperative antibiotics did not prevent infection in all cases.

Conclusions:

  • Standard perioperative antibiotic regimens were associated with an 8% infection rate in m-c flap surgeries for spinal cord injury.
  • The high prevalence of Bacteroides sp. suggests anaerobic bacteria are significant pathogens.
  • Future antibiotic strategies should consider coverage for anaerobic bacteria in these patients.

Related Concept Videos